New AHA board chairperson driven to improve health care
Lee Shapiro, the new American Heart Association board chairperson, is partner and co-founder of 7wire Ventures.
Lee Shapiro, the new American Heart Association board chairperson, is partner and co-founder of 7wire Ventures.
Combined company creates an industry leading platform with more than 1,400 employer and payer clients, with shared focus on consumer empowerment. Transcarent’s Generative AI WayFinding and care experiences combined with Accolade’s Advocacy, Expert Medical Opinion, and Primary Care will deliver on the promise of ‘One Place for Health and Care’.
Over 10 years after we first started supporting founders in bringing innovation and progress to healthcare, we are excited to unveil a refreshed brand identity for 7wire Ventures. With a new logo, website, and marketing collateral, we are changing the look of our brand but not our commitment to transforming healthcare.
We are thrilled to announce that 7wireVentures has led an investment in Summer Health as part of the company’s $10M Series A financing round.
We are thrilled to announce that 7wireVentures has led an investment in Summer Health as part of the company’s $10M Series A financing round.
Following a prolific 38-year career at Cigna, Richards brings his extensive health plan and employer expertise to 7wireVentures, helping drive enhanced growth across the firm’s portfolio
We’re excited to officially kick off recruiting for our 7wireVentures 2022 MBA Summer Internship Program!
We are pleased to announce that 7wireVentures has raised our latest investment vehicle, a $217M Growth & Opportunity Fund (GO Fund). The new capital will help our team support high-potential companies from our existing portfolio as they advance to later stages of funding, as well as to invest in other compelling Series B and C companies. The closing of our GO Fund brings the Firm’s AUM to over $500M.
Vivante Health, a digital digestive health solution that uniquely addresses the main challenges consumers with Gastrointestinal (GI) conditions face through personalized clinical care, announced a $31M equity financing Series B led by Mercato Partners.